Stock comparison
Bruker
IDEXX Laboratories
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BRKR
Bruker
Market cap
$6.96B
Sector
Healthcare
IDXX
IDEXX Laboratories
Market cap
$44.12B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BRKR | IDXX | Winner |
|---|---|---|---|
| Warren Buffett | 33F | 75B | IDXX |
| Benjamin Graham | 44D | 80A | IDXX |
| Philip Fisher |
Side-by-side metrics
| Metric | BRKR | IDXX |
|---|---|---|
| Market cap | $6.96B | $44.12B |
| P/E (TTM) | - | 39.0x |
| EV/EBIT | 34.2x | 31.6x |
| ROIC (TTM) | -2.92% | 40.66% |
| Gross margin | 45.56% | 62.05% |
| Net margin | -0.34% | 24.63% |
| Revenue CAGR 5y | 9.19% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BRKR leads on
- P/E (TTM)-vs 39.0x+107%
- Dividend yield0.47%vs 0.0%+100%
- Revenue CAGR 5y9.19%vs 7.56%+18%
IDXX leads on
More like IDXX
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.